Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11953-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11953-1-AP, RRID:AB_874230
- Product name
- TRIM6 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated TRIM6 antibody (Cat. #11953-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, WB, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references TRIM6 facilitates SARS-CoV-2 proliferation by catalyzing the K29-typed ubiquitination of NP to enhance the ability to bind viral genomes.
TRIM6 promotes glioma malignant progression by enhancing FOXO3A ubiquitination and degradation.
TRIM6 Reduces Ferroptosis and Chemosensitivity by Targeting SLC1A5 in Lung Cancer.
TRIM6 silencing for inhibiting growth and angiogenesis of gliomas by regulating VEGFA.
Tripartite Motif Protein 6 Promotes Colorectal Cancer Cell Migration and Metastasis via SOCS2-STAT3 Signaling.
TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1.
Zhou J, Zhou Y, Wei XF, Fan L, Gao X, Li Y, Wu Y, Feng W, Shen X, Liu L, Xu G, Zhang Z
Journal of medical virology 2024 Mar;96(3):e29531
Journal of medical virology 2024 Mar;96(3):e29531
TRIM6 promotes glioma malignant progression by enhancing FOXO3A ubiquitination and degradation.
Guo J, Wang J, Zhang P, Wen P, Zhang S, Dong X, Dong J
Translational oncology 2024 Aug;46:101999
Translational oncology 2024 Aug;46:101999
TRIM6 Reduces Ferroptosis and Chemosensitivity by Targeting SLC1A5 in Lung Cancer.
Zhang Y, Dong P, Liu N, Yang JY, Wang HM, Geng Q
Oxidative medicine and cellular longevity 2023;2023:9808100
Oxidative medicine and cellular longevity 2023;2023:9808100
TRIM6 silencing for inhibiting growth and angiogenesis of gliomas by regulating VEGFA.
Liu X, Zhao J, Dong P, Du X, Lu W, Feng Y, Wang L
Journal of chemical neuroanatomy 2023 Oct;132:102291
Journal of chemical neuroanatomy 2023 Oct;132:102291
Tripartite Motif Protein 6 Promotes Colorectal Cancer Cell Migration and Metastasis via SOCS2-STAT3 Signaling.
Zhao H, Huang J, Chen M, Li B, Chen X, Zhou M
Frontiers in oncology 2021;11:695525
Frontiers in oncology 2021;11:695525
TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1.
Zheng S, Zhou C, Wang Y, Li H, Sun Y, Shen Z
Journal of experimental & clinical cancer research : CR 2020 Jan 28;39(1):23
Journal of experimental & clinical cancer research : CR 2020 Jan 28;39(1):23
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- COLO 320 cells were subjected to SDS PAGE followed by western blot with 11953-1-AP(TRIM6 antibody) at dilution of 1:600
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The TRIM6 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human TRIM6. This antibody recognizes human, mouse, rat antigen. The TRIM6 antibody has been validated for the following applications: ELISA, WB, IHC analysis.